Buprenorphine Hydrochloride

Buprenorphine Oral Lyophilisate is a rapidly dispersing formulation designed for the treatment of opioid dependence as part of a comprehensive care program including medical, social, and psychological support. The product contains buprenorphine, a partial opioid agonist that helps reduce withdrawal symptoms and cravings while supporting patient stabilization. The oral lyophilisate is placed on the tongue, where it dissolves quickly, allowing efficient absorption through the oral mucosa. This formulation offers an alternative to conventional sublingual tablets, with faster disintegration and simplified administration. Available in 2 mg and 8 mg strengths, it enables flexible dose titration for induction, maintenance, and dose reduction phases under medical supervision.